During the recent session, Teladoc Health Inc (NYSE:TDOC)’s traded shares were 1.45 million, with the beta value of the company hitting 1.80. At the last check today, the stock’s price was $7.21, reflecting an intraday gain of 3.39% or $0.24. The 52-week high for the TDOC share is $15.21, that puts it down -110.96 from that peak though still a striking 11.93% gain since the share price plummeted to a 52-week low of $6.35. The company’s market capitalization is $1.26B, and the average trade volume was 5.67 million shares over the past three months.
Teladoc Health Inc (TDOC) received a consensus recommendation of Hold from analysts. That translates to a mean rating of 2.54. TDOC has a Sell rating from 0 analyst(s) out of 19 analysts who have looked at this stock. 10 analyst(s) recommend to Hold the stock while 0 suggest Overweight, and 9 recommend a Buy rating for it. 0 analyst(s) has rated the stock Underweight. Company’s earnings per share (EPS) for the current quarter are expected to be -0.3.
Teladoc Health Inc (NYSE:TDOC) trade information
Teladoc Health Inc (TDOC) registered a 3.39% upside in the last session and has traded in the green over the past 5 sessions. The stock spiked 3.39% in intraday trading to $7.21, hitting a weekly high. The stock’s 5-day price performance is 3.39%, and it has moved by -1.69% in 30 days. Based on these gigs, the overall price performance for the year is -37.23%.
The consensus price target of analysts on Wall Street is $13, which implies an increase of 44.54% to the stock’s current value. The extremes of the forecast give a target low and a target high price of $13 and $13 respectively. As a result, TDOC is trading at a discount of -80.31% off the target high and -80.31% off the low.
Teladoc Health Inc (TDOC) estimates and forecasts
In the rating firms’ projections, revenue will decrease -2.12% compared to the previous financial year.
As companies strive to predict their financial trajectories, we turn our attention to the forthcoming financial quarter. Here are the insights gathered from industry analysts. Revenue for the current quarter is expected to be 622.01M as predicted by 22 analyst(s). Meanwhile, a consensus of 22 analyst(s) estimates revenue growth to 627.76M by the end of current fiscal year. As per earnings report from last fiscal year’s results, sales for the corresponding quarters totaled 642.44M and 640.51M respectively. In this case, analysts expect current quarter sales to shrink by -3.18% and then drop by -1.99% in the coming quarter.
An analysis of the company’s performance over the past 5 years shows that the company’s earnings shrunk an estimated -33.66%. While earnings are projected to return 80.71% in 2025, the next five years will return 46.21% per annum.
TDOC Dividends
Teladoc Health Inc is due to release its next quarterly earnings in June. However, it is important to remember that the dividend yield ratio is merely an indicator meant to only serve as guidance.
Teladoc Health Inc (NYSE:TDOC)’s Major holders
The next largest institutional holding, with 17.22 million shares, is of VANGUARD GROUP INC’s that is approximately 10.1136% of outstanding shares. At the market price on 2024-06-30, these shares were valued at $168.38 million.
Also, the Mutual Funds coming in first place with the largest holdings of Teladoc Health Inc (TDOC) shares are VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund and iShares Trust-iShares Russell 2000 ETF. Data provided on Mar 31, 2025 indicates that VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund owns about 5.45 shares. This amounts to just over 3.11 percent of the company’s overall shares, with a $39.23 million market value. The same data shows that the other fund manager holds slightly less at 4.6, or about 2.62% of the stock, which is worth about $33.07 million.
